Jpmorgan Chase & CO Cumberland Pharmaceuticals Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 219 shares of CPIX stock, worth $497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219
Previous 20
995.0%
Holding current value
$497
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CPIX
# of Institutions
23Shares Held
1.97MCall Options Held
44.2KPut Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny528KShares$1.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$849,5490.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX287KShares$650,7060.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX284KShares$644,6910.0% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$427,1320.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $33.3M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...